Cosyntropin Injection Shortage
Last Updated: January 3, 2024
Status: Current
Products Affected - Description
-
- Cosyntropin lyophilized powder for injection, Mylan Institutional (Viatris), 0.25 mg, vial, 10 count, NDC 67457-0227-02 - discontinued
Reason for the Shortage
-
- Amphastar has Cortrosyn available.
- Viatris discontinued cosyntropin in November 2023.
- Sandoz has cosyntropin available.
Available Products
-
- Cortrosyn lyophilized powder for injection, Amphastar, 0.25 mg, vial, 10 count, NDC 00548-5900-00
- Cosyntropin lyophilized powder for injection, Sandoz, 0.25 mg, vial, 10 count, NDC 00781-3440-95
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated January 3, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 22, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.